Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Hypertension is considered a risk factor in immunoglobulin A nephropathy (IgAN). However, after IgAN diagnosis, the relationship between early blood pressure control and renal prognosis remains unclear. This study aimed to analyze the association between the prognosis of IgAN patients and a controlled status of hypertension within the first year of IgAN diagnosis. Methods: We retrospectively analyzed 2,945 patients diagnosed with IgAN by renal biopsy. The patients were divided into ‘normal,’ ‘new-onset,’ ‘well-controlled,’ and ‘poorly-controlled’ groups using blood pressure data from two consecutive measurements performed within a year. The Kaplan-Meier survival analysis and Cox proportional-hazards regression model were used to survey the independent association between recovery from hypertension and the risk of IgAN progression. The primary endpoint was IgAN progression defined as the initiation of dialysis or kidney transplantation. Results: Before IgAN diagnosis, 1,239 patients (42.1%) had been diagnosed with hypertension. In the fully adjusted Cox proportional-hazards models, the risk of IgAN progression increased by approximately 1.7-fold for the prevalence of hypertension. In the subgroup analyses, the ‘well-controlled’ group showed a statistically significant risk of IgAN progression (hazard ratio [HR], 3.19; 95% confidence interval [CI], 1.103 to 9.245; p = 0.032). Moreover, the ‘new-onset’ and ‘poorly-controlled’ groups had an increased risk of IgAN progression compared to the ‘normal’ group (HR, 2.58; 95% CI, 1.016 to 6.545; p = 0.046 and HR, 3.85;95% CI, 1.541 to 9.603; p = 0.004, respectively). Conclusions: Although hypertension was well-controlled in the first year after IgAN diagnosis, it remained a risk factor for IgAN progression.
Abstract
Background/Aims: Hypertension is considered a risk factor in immunoglobulin A nephropathy (IgAN). However, after IgAN diagnosis, the relationship between early blood pressure control and renal prognosis remains unclear. This study aimed to analyze the association between the prognosis of IgAN patients and a controlled status of hypertension within the first year of IgAN diagnosis. Methods: We retrospectively analyzed 2,945 patients diagnosed with IgAN by renal biopsy. The patients were divided into ‘normal,’ ‘new-onset,’ ‘well-controlled,’ and ‘poorly-controlled’ groups using blood pressure data from two consecutive measurements performed within a year. The Kaplan-Meier survival analysis and Cox proportional-hazards regression model were used to survey the independent association between recovery from hypertension and the risk of IgAN progression. The primary endpoint was IgAN progression defined as the initiation of dialysis or kidney transplantation. Results: Before IgAN diagnosis, 1,239 patients (42.1%) had been diagnosed with hypertension. In the fully adjusted Cox proportional-hazards models, the risk of IgAN progression increased by approximately 1.7-fold for the prevalence of hypertension. In the subgroup analyses, the ‘well-controlled’ group showed a statistically significant risk of IgAN progression (hazard ratio [HR], 3.19; 95% confidence interval [CI], 1.103 to 9.245; p = 0.032). Moreover, the ‘new-onset’ and ‘poorly-controlled’ groups had an increased risk of IgAN progression compared to the ‘normal’ group (HR, 2.58; 95% CI, 1.016 to 6.545; p = 0.046 and HR, 3.85;95% CI, 1.541 to 9.603; p = 0.004, respectively). Conclusions: Although hypertension was well-controlled in the first year after IgAN diagnosis, it remained a risk factor for IgAN progression.
참고문헌 (34)
- 진동찬, "Renal replacement therapy in Korea, 2012", Kidney Research and Clinical Practice, 33(1), pp.9~18 (2014), 대한신장학회
- Chang JH, "Changing prevalence of glomerular diseases in Korean adults : a review of 20 years of experience", Nephrol Dial Transplant, 24, pp.2406~2410 (2009)
- Wyatt RJ, "IgA nephropathy", N Engl J Med, 368, pp.2402~2414 (2013)
- Moriyama T, "Prognosis in IgA nephropathy : 30-year analysis of 1, 012 patients at a single center in Japan", PLoS One, 9, pp.e91756~ (2014)
- Hunsicker LG, "The consequences and costs of chronic kidney disease before ESRD", J Am Soc Nephrol, 15, pp.1363~1364 (2004)
- 김경민, "Impact of chronic kidney disease on mortality: A nationwide cohort study", Kidney Research and Clinical Practice, 38(3), pp.382~390 (2019), 대한신장학회[DOI]
- Radford MG Jr, "Predicting renal outcome in IgA nephropathy", J Am Soc Nephrol, 8, pp.199~207 (1997)
- Wakai K, "A scoring system to predict renal outcome in IgA nephropathy : from a nationwide prospective study", Nephrol Dial Transplant, 21, pp.2800~2808 (2006)
- Yamamoto R, "Cigarette smoking and progression of IgA nephropathy", Am J Kidney Dis, 56, pp.313~324 (2010)
- Szeto CC, "The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria", Am J Med, 110, pp.434~437 (2001)
- Syrjanen J, "Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy", Nephrol Dial Transplant, 15, pp.34~42 (2000)
- Kiryluk K, "Pathogenesis of immunoglobulin A nephropathy : recent insight from genetic studies", Annu Rev Med, 64, pp.339~356 (2013)
- Kiryluk K, "Geographic differences in genetic susceptibility to IgA nephropathy : GWAS replication study and geospatial risk analysis", PLoS Genet, 8, pp.e1002765~ (2012)
- Cattran DC, "Kidney disease : improving global outcomes(KDIGO)glomerulonephritis work group : KDIGO clinical practice guideline for glomerulonephritis", Kidney Int Suppl, 2, pp.139~274 (2012)
- "Nutritional anaemias: report of a WHO scientific group", World Health Organ Tech Rep Ser, 405, pp.5~37 (1968)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Modification of Diet in Renal Disease Study Group", Ann Intern Med, 130, pp.461~470 (1999)
- Van Buuren S, "Mice : multivariate imputation by chained equations in R", J Stat Softw, 45, pp.1~67 (2010)
- Pedersen AB, "Missing data and multiple imputation in clinical epidemiological research", Clin Epidemiol, 9, pp.157~166 (2017)
- Madley-Dowd P, "The proportion of missing data should not be used to guide decisions on multiple imputation", J Clin Epidemiol, 110, pp.63~73 (2019)
- "R: A language and environment for statistical computing 2019" (2020)[URL]
- Diciolla M, "Patient classification and outcome prediction in IgA nephropathy", Comput Biol Med, 66, pp.278~286 (2015)
- Knoop T, "Addition of eGFR and age improves the prognostic absolute renal risk-model in 1, 134 Norwegian patients with IgA nephropathy", Am J Nephrol, 41, pp.210~219 (2015)
- Chacko B, "Presentation, prognosis and outcome of IgA nephropathy in Indian adults", Nephrology(Carlton), 10, pp.496~503 (2005)
- Le W, "Long-term renal survival and related risk factors in patients with IgA nephropathy : results from a cohort of 1155 cases in a Chinese adult population", Nephrol Dial Transplant, 27, pp.1479~1485 (2012)
- Berthoux F, "Predicting the risk for dialysis or death in IgA nephropathy", J Am Soc Nephrol, 22, pp.752~761 (2011)
- Woo KT, "Hypertension in IgA nephropathy", Ann Acad Med Singapore, 17, pp.583~588 (1988)
- Upadhyay A, "Systematic review : blood pressure target in chronic kidney disease and proteinuria as an effect modifier", Ann Intern Med, 154, pp.541~548 (2011)
- Zheng Y, "Potential blood pressure goals in IgA nephropathy : prevalence, awareness, and treatment rates in chronic kidney disease among patients with hypertension in China(PATRIOTIC)Study", Kidney Blood Press Res, 43, pp.1786~1795 (2018)
- Olson JL, "Heptinstall’s Pathology of the Kidney", pp.943~1002 (1998), Lippincott-Raven
- Bidani AK, "Pathophysiology of hypertensive renal damage : implications for therapy", Hypertension, 44, pp.595~601 (2004)
- Bidani AK, "Long-term renal consequences of hypertension for normal and diseased kidneys", Curr Opin Nephrol Hypertens, 11, pp.73~80 (2002)
- Praga M, "Treatment of IgA nephropathy with ACE inhibitors : a randomized and controlled trial", J Am Soc Nephrol, 14, pp.1578~1583 (2003)
- Konishi Y, "Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy", Hypertension, 38, pp.81~85 (2001)
- Greene T, "Randomized and observational studies in nephrology : how strong is the evidence?", Am J Kidney Dis, 53, pp.377~388 (2009)